Carisma Therapeutics Inc. Current Assets
Carisma Therapeutics Inc. had Current Assets of $5.87 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-11-12
- 2025-09-30: Assets, Current $5.87M.
- 2025-06-30: Assets, Current $4.29M.
- 2025-03-31: Assets, Current $13.95M.
- 2024-12-31: Assets, Current $23.82M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2025-09-30 | $5.87M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $4.29M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $13.95M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $23.82M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $34.14M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $50.72M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $60.95M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $80.47M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $97.56M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $122.20M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $144.50M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $54.59M 10-K · filed 2024-04-01 | $189.14M 10-K · filed 2023-02-28 |
| 2022-09-30 | $192.36M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $156.42M 10-Q/A · filed 2022-08-25 | |
| 2022-03-31 | $180.64M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $205.60M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $200.48M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $175.10M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $126.58M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $62.87M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $49.04M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $41.47M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $44.88M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $54.45M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $59.41M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $67.53M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $45.45M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $51.76M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $59.38M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $63.77M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $20.33M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $14.98M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $12.11M 10-Q · filed 2017-11-17 | |
| 2017-06-30 | $16.46M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $20.98M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $25.93M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $31.81M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $8.83M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $13.81M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $36.31M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $47.02M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $54.43M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $46.14M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $54.40M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $36.29M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $46.03M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $54.41M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $8.03M 10-K · filed 2015-03-06 |